Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**UT 380** is a long-acting, non-hormonal *copper-based intrauterine device (IUD)* used for contraception. Its main active ingredient is copper, which is wound around a flexible polyethylene frame. Once inserted into the uterus, the copper ions exert a cytotoxic effect on sperm and egg, inhibiting fertilization and preventing implantation of a fertilized egg. It is effective immediately upon insertion and can be used both as a regular contraceptive method and as emergency contraception if inserted within 5 days (some sources specify up to 7 days) after unprotected intercourse. The device is reversible, suitable for a range of women (nulliparous, primiparous, multiparous), and provides protection for up to 5 years. UT 380 contains barium sulphate for radiopacity and includes a nylon thread for removal[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on UT 380.